Press releases

All Releases
View Summary Aastrom Biosciences Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
Sep 17, 2014
PDF 12.3 KB Add to Briefcase
View Summary Aastrom Biosciences to Present Three-Year Data From the SUMMIT Extension Study of MACI(TM) at the 2015 American Academy of Orthopedic Surgeons Annual Meeting
Sep 16, 2014
PDF 11.4 KB Add to Briefcase
View Summary Aastrom Biosciences Announces Pricing of Public Offering of Common Stock
Sep 11, 2014
PDF 12.8 KB Add to Briefcase
View Summary Treatment With Aastrom's Ixmyelocel-T Shown to Reduce Incidence of Major Adverse Cardiovascular Events in Patients With Ischemic Dilated Cardiomyopathy
Aug 22, 2014
PDF 13.0 KB Add to Briefcase
View Summary Aastrom Biosciences Reports Second Quarter 2014 Financial Results
Aug 14, 2014
PDF 361.2 KB Add to Briefcase
View Summary Aastrom Biosciences to Host Second Quarter 2014 Earnings Call on August 14, 2014
Aug 11, 2014
PDF 12.7 KB Add to Briefcase
View Summary Aastrom Announces Appointment of Zac Taylor as National Sales Director
Jul 14, 2014
PDF 11.3 KB Add to Briefcase
View Summary Aastrom Biosciences Added to Russell Microcap Index
Jun 30, 2014
PDF 11.7 KB Add to Briefcase
View Summary Aastrom Announces Initiation of Commercial Sales of Bone Marrow by Marrow Donation, LLC
Jun 24, 2014
PDF 11.0 KB Add to Briefcase
View Summary Aastrom Announces Strategic Plan for Recently Acquired Cell Therapy and Regenerative Medicine Business
Jun 16, 2014
PDF 17.8 KB Add to Briefcase
View Summary Aastrom Announces Investor Conference Call and Webcast June 16, 2014 at 8:30 AM EDT
Jun 15, 2014
PDF 12.1 KB Add to Briefcase
View Summary Aastrom Announces Appointment of Gerard Michel as Chief Financial Officer and Vice President, Corporate Development
Jun 4, 2014
PDF 11.1 KB Add to Briefcase
View Summary Aastrom Completes Acquisition of Sanofi's Cell Therapy and Regenerative Medicine Business
Jun 2, 2014
PDF 11.3 KB Add to Briefcase
View Summary Aastrom Biosciences Reports First-Quarter 2014 Financial Results
May 15, 2014
PDF 18.1 KB Add to Briefcase
View Summary Aastrom Biosciences to Host First Quarter 2014 Investor Call on May 15, 2014
May 9, 2014
PDF 12.8 KB Add to Briefcase
View Summary Aastrom to Hold Annual Meeting of Shareholders on May 7, 2014
May 2, 2014
PDF 11.0 KB Add to Briefcase
View Summary Aastrom Announces Definitive Agreement to Acquire Sanofi's Cell Therapy and Regenerative Medicine Business
Apr 21, 2014
PDF 12.4 KB Add to Briefcase
View Summary Aastrom Reports Data and Safety Monitoring Board Recommendation to Continue ixCELL-DCM Clinical Trial
Apr 9, 2014
PDF 11.2 KB Add to Briefcase
View Summary Aastrom Announces Appointments of Dr. Ross Tubo as Chief Scientific Officer and Dr. David Recker as Chief Medical Officer
Apr 1, 2014
PDF 12.0 KB Add to Briefcase
View Summary Aastrom Biosciences to Present at the 2014 Regen Med Investor Day
Mar 19, 2014
PDF 11.3 KB Add to Briefcase
Showing 1-20 of 361 Page: 1 2 3 4 5 ... 19  Next 20
Add to Briefcase = add release to Briefcase
Stock Information
NASDAQ: ASTM
Price:
2.74
Change:
+ 0.04
Day High:
2.75
Day Low:
2.63
Volume:
341,600
4:00 PM ET on Sep 19, 2014
Delayed at least 20 minutes.
Provided by eSignal.

Shareholder Tools